St and Photosensitivity: Side Effects & Sun Protection
Does st john's wort photosensitivity cause photosensitivity? Learn about this side effect and how to protect yourself from sun and light reactions.
For informational purposes only. This site exists to help people with light sensitivity live more comfortably — it does not provide medical advice, diagnoses, or treatment recommendations. Always consult your doctor or a qualified healthcare provider before making any health decisions. Read our full disclaimer →
- St. John's Wort (Hypericum perforatum) is one of the best-documented herbal photosensitizers — its active compound hypericin accumulates in skin and generates phototoxic reactions under UV exposure.
- Photosensitivity risk is dose-dependent and highest at high doses (>2mg hypericin/day) — standard commercial doses (typically 0.3% hypericin) carry lower but still real risk.
- Fair-skinned individuals and those with high outdoor UV exposure are at significantly higher risk of reaction.
- SPF 50+ broad-spectrum sunscreen is recommended throughout St. John's Wort supplementation — reactions can occur after tolerable sun exposure.
- St. John's Wort also inhibits CYP3A4 and interacts significantly with many medications (warfarin, hormonal contraceptives, cyclosporine, antiretrovirals) — these drug interactions are often more clinically significant than the photosensitivity.
St. John’s Wort (Hypericum perforatum) is one of the most widely used herbal supplements globally, taken primarily for mild-to-moderate depression and anxiety. It is one of the few herbal supplements with a well-established, clinically significant drug-induced photosensitivity risk — and it causes photosensitivity through a unique mechanism not shared by most pharmaceutical drugs.
Why St. John’s Wort Causes Photosensitivity
The primary photosensitizing compound in St. John’s Wort is hypericin — a naphthodianthrone pigment that gives the plant its characteristic red oil (visible when crushing the flower petals). Hypericin is a potent photosensitizer:
- Hypericin absorbs UV-A and visible light (peak absorption ~590nm, in the visible red spectrum)
- The excited hypericin molecule generates singlet oxygen and reactive oxygen species
- These reactive species cause oxidative damage to skin cells and potentially retinal cells
Unlike most drug photosensitizers that cause phototoxicity at UV-A wavelengths only, hypericin’s absorption of visible light means that even indoor lighting and visible daylight can trigger reactions in highly exposed individuals — not just direct UV sunlight.
Clinical Presentation
St. John’s Wort photosensitivity causes:
- Erythema, burning, and edema in sun-exposed skin
- Blistering and vesiculation in severe cases (more common with very high doses)
- Predominantly affects light-skinned individuals
- Generally mild at typical supplement doses (300mg standardized extract 3×/day)
- More severe reactions documented in livestock grazing on Hypericum plants in full sunlight — historically the first recognized hypericin toxicity
Clinical Risk Assessment
At standard supplement doses (900mg/day total), clinically significant photosensitivity is relatively uncommon but does occur. Risk is higher with:
- High doses or concentrated extracts
- Fair skin (phototype I–II)
- Intense sun exposure (outdoor work, beach, high altitude)
- Concurrent use of other photosensitizing medications (additive risk)
Drug Interactions (Critical)
Beyond photosensitivity, St. John’s Wort induces CYP3A4 — a major liver enzyme. This causes clinically significant interactions with many medications, reducing their blood levels:
- Oral contraceptives (pregnancy risk)
- Antiretrovirals (HIV treatment failure)
- Cyclosporine (transplant rejection)
- Warfarin (thrombosis risk)
- Many other drugs
Patients and clinicians must screen for drug interactions before starting St. John’s Wort regardless of the photosensitivity concern.
Prevention and Management
- Apply broad-spectrum SPF 30–50+ sunscreen before sun exposure
- Protective clothing and hat for prolonged outdoor activities
- No special management needed beyond sun protection at standard doses
- If significant photosensitivity occurs: reduce dose or discontinue; reactions typically resolve within days to weeks
- Patients with history of severe phototoxic reactions or on multiple photosensitizing drugs should consider pharmaceutical antidepressants instead
Sources
- Brockmoller J, et al. “Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.” Pharmacopsychiatry. 1997;30(Suppl 2):94-101.
- Schempp CM, et al. “Topical application of St. John’s Wort.” Phytomedicine. 2000.
- Linde K, et al. “St John’s wort for depression.” Cochrane Database Syst Rev. 2008.